Canaccord Genuity Maintains Buy on Staar Surgical, Raises Price Target to $45

Canaccord Genuity maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $40 to $45.

Benzinga · 11/11/2019 13:28

Canaccord Genuity maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $40 to $45.